Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium Wilfordii for IgG4-Related Disease
NCT07878585Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Tripterygium wilfordii in IgG4-related disease (IgG4-RD), sponsored by Peking Union Medical College Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Tripterygium wilfordii
03
Conditions
IgG4-related disease (IgG4-RD)
Beyond the preview
Go deeper on NCT07878585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07878585.